2019
DOI: 10.1007/s40477-019-00377-2
|View full text |Cite
|
Sign up to set email alerts
|

The comparison of accuracy of ultrasonographic features versus ultrasound-guided fine-needle aspiration cytology in diagnosis of malignant thyroid nodules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
12
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 39 publications
5
12
1
Order By: Relevance
“…27 In the present study, hypoechogenicity as one of sonographic characteristics was the most worth measure to predict malignancy (91.5%), with 0.96% sensitivity, 87% specificity and 92% accuracy. Other studies by Nabahati et al, 14 and Alam et al, 28 have reported that hypoechogenicity was most anticipated scale for malignancy, these rates were observed, (53% sensitivity, 77% specificity), (42% sensitivity and 75% specificity), respectively, which were in contrast to our data. Furthermore, in conflict with our results, in another study by Sankhla et al, 2001, found 33% of hypoechoic malignant nodules and 11% of hyperechoic malignant nodules.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…27 In the present study, hypoechogenicity as one of sonographic characteristics was the most worth measure to predict malignancy (91.5%), with 0.96% sensitivity, 87% specificity and 92% accuracy. Other studies by Nabahati et al, 14 and Alam et al, 28 have reported that hypoechogenicity was most anticipated scale for malignancy, these rates were observed, (53% sensitivity, 77% specificity), (42% sensitivity and 75% specificity), respectively, which were in contrast to our data. Furthermore, in conflict with our results, in another study by Sankhla et al, 2001, found 33% of hypoechoic malignant nodules and 11% of hyperechoic malignant nodules.…”
Section: Discussioncontrasting
confidence: 99%
“…According to our results, calcification was related to low specificity (0.71%), but high sensitivity (0.96%), which was in contrast with the previously published data like, Alam et al, 2014, Kim et al, 2002, Papini et al, 2002 and Nabahati et al, 2019. 14,28,30,31 Of course, some studies are in agreement with our results, which showed a higher rate of sensitivity such as Xu et al,2017, 32 moreover, microcalcification was associated with malignancy (97.0%) and benign (3.0%), but there were conflicting data about absent, eggshell, coarse, and macrocalcification such as studies published from Petrone et al, 2012, Kim et al, 2013, and Park et al, 2014. 33-35 A study by Koike et al, 2001, 36 indicated that calcification had a sensitivity of 88.7% and Ram et al, 2015 showed a high sensitivity (80%) and a relatively lower specificity (68%) for calcification, 19 results of these two studies are relatively close to our findings for calcification (both micro as well as macro).…”
Section: Discussionmentioning
confidence: 99%
“…According to our experience, like some other studies [19,20], the size of the nodules is not a good indicator of the risk of malignancy of thyroid nodules. However, some researches claim that there is a strong association between these two factors as the larger size of the nodules correlates with a higher malignancy rate with a threshold of 2.0 cm [21,22].…”
Section: Discussionsupporting
confidence: 44%
“…Although there is a potential bias in our cohort due to its restriction to surgically managed nodules, it is challenging to better define outcome; of note, some related studies have evaluated clinical and sonographic variables against cytologic (rather than histologic) outcome, but this approach is suboptimal and prohibits the use of cytology as an input variable 16,24,25 . Alternately, while long‐term clinical follow‐up and/or “benign” FNA molecular testing might be utilized as outcome surrogates for non‐surgically managed nodules, they each have significant limitations, notably, the variable accuracy of the different available molecular tests and the slow progression of most thyroid cancers.…”
Section: Discussionmentioning
confidence: 99%